Table 1.
Cell type | Description |
---|---|
Adaptive Th17 cells | • A subset of activated CD4+ T helper cells that produce high levels of IL-17A, IL-17F, and IL-22, and express IL-23R • CD4+ TCRα/β+ Th17 cells are a well characterized source of IL-17 that play a key role in immune inflammatory responses |
Natural Th17 cells | • Subset of thymic Th17 cells that acquire effector function prior to peripheral antigen exposure • These cells have different TCR gene usage and signaling properties compared with conventional Th17 cells |
γ/δ T cells | • Potent source of innate IL-17 produced independently of IL-6 • Properties are similar to Th17 cells (e.g., expression of CCR6, IL-23R, and RORγt); these cells also express TLR1, TLR2, and Dectin-1 • Levels of IL-17-producing γ/δ T cells increase during some types of bacterial infections • Different subsets of γ/δ T cells in the thymus produce either IL-17 or IFNγ • Major source of gut-protective IL-17, which acts independently from IL-23 |
iNKT cells | • Cells that express a restricted TCR that recognizes glycolipid antigens • May provide an alternative source of IL-17 when IL-6 is not present to stimulate Th17 cells • IL-17+ cells express IL-23R and IL-1R1 |
Tc17 cells | • Subset of CD8+ cells that produces IL-17 • May play a role in pathogenic skin and joint inflammation in psoriasis and PsA, respectively |
ILC3s | • Subset of ILCs defined by their capacity to produce IL-17A and/or IL-22 • The role of ILCs in SpA and other forms of destructive arthritis is unclear because cell numbers are generally low |
Neutrophils | • Source of IL-17 in effector phase of arthritis • Myeloperoxidase+ and CD15+ neutrophils have been identified as sources of IL-17 in facet joints of patients with SpA |
Mast cells | • Primary source of IL-17+ cells in synovial fluid of patients with SpA as a result of innate immune responses |
CCR6 C-C chemokine receptor type 6, IFN interferon, IL interleukin, ILC innate lymphoid cell, iNKT cells invariant natural killer T cells, PsA psoriatic arthritis, ROR retinoic orphan receptor, SpA spondyloarthritis, TCR T-cell receptor, Th T-helper, TLR Toll-like receptor